{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:23Z","timestamp":1790713223078,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.radonc.2015.08.030","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T01:17:54Z","timestamp":1441675074000},"page":"183-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma"],"prefix":"10.1016","volume":"117","clinical-trial-number":[{"clinical-trial-number":"nct00458484","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lee","family":"Ponsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schluchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Abouassaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Welford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gulani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Robert","family":"Haaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Machtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.08.030_b0005","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","article-title":"Rising incidence of renal cell cancer in the United States","volume":"281","author":"Chow","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2015.08.030_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0022-5347(05)00148-5","article-title":"The natural history of observed enhancing renal masses: meta-analysis and review of the world literature","volume":"175","author":"Chawla","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2015.08.030_b0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","article-title":"Guideline for management of the clinical T1 renal mass","volume":"182","author":"Campbell","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2015.08.030_b0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.juro.2006.10.073","article-title":"Enhancing renal masses with zero net growth during active surveillance","volume":"177","author":"Kunkle","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2015.08.030_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.urolonc.2006.07.018","article-title":"Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar","volume":"25","author":"Siu","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.juro.2007.08.124","article-title":"Renal mass biopsy\u2013a renaissance?","volume":"179","author":"Lane","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2015.08.030_b0035","doi-asserted-by":"crossref","first-page":"g4797","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2015.08.030_b0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3816\/CGC.2007.n.013","article-title":"Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery","volume":"5","author":"Teh","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.radonc.2015.08.030_b0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0090-4295(02)02442-1","article-title":"Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation","volume":"61","author":"Ponsky","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2015.08.030_b0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrclinonc.2009.188","article-title":"Stereotactic body radiation therapy: a novel treatment modality","volume":"7","author":"Lo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.030_b0060","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2217\/fon.14.13","article-title":"Emerging applications of stereotactic body radiotherapy","volume":"10","author":"Lo","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0065","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/02841860600954875","article-title":"A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma","volume":"45","author":"Svedman","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","article-title":"Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma","volume":"77","author":"Wersall","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.coc.0000145289.57705.07","article-title":"Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma","volume":"27","author":"Beitler","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1553350607310546","article-title":"Renal radiosurgery: initial clinical experience with histological evaluation","volume":"14","author":"Ponsky","year":"2007","journal-title":"Surg Innov"},{"key":"10.1016\/j.radonc.2015.08.030_b0085","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2015.08.030_b0090","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0095","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.030_b0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ijrobp.2008.02.060","article-title":"Stereotactic body radiosurgery for spinal metastases: a critical review","volume":"71","author":"Sahgal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.030_b0105","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.ijrobp.2013.06.218","article-title":"A phase 1 dose-escalation study of robotic radiosurgery in inoperable primary renal cell carcinoma","volume":"87","author":"McBride","year":"2013","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.030_b0110","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2014.07.043","article-title":"Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity","volume":"90","author":"Pham","year":"2014","journal-title":"Int J Rad Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:57:16Z","timestamp":1537361836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015004557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0167814015004557"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}